Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe

basilar artery occlusion

  • Home
  • basilar artery occlusion
Endovascular Thrombectomy for Basilar Artery Occlusion: 3-Year Outcomes Confirm Durable Clinical Benefits
Posted inNeurology news Radiology

Endovascular Thrombectomy for Basilar Artery Occlusion: 3-Year Outcomes Confirm Durable Clinical Benefits

Posted by MedXY By MedXY 01/01/2026
Long-term data from the ATTENTION trial reveal that endovascular thrombectomy significantly improves functional outcomes and survival at three years for patients with basilar artery occlusion, establishing it as a durable standard of care.
Read More
Pretransfer IV Thrombolysis in Basilar Artery Occlusion: Improved Recanalization and 3‑Month Outcomes Without Clear Safety Signals
Posted inNeurology news

Pretransfer IV Thrombolysis in Basilar Artery Occlusion: Improved Recanalization and 3‑Month Outcomes Without Clear Safety Signals

Posted by MedXY By MedXY 12/06/2025
In transferred patients with basilar artery occlusion (BAO), IV thrombolysis before transfer was associated with higher rates of basilar recanalization and better 3‑month functional outcomes, with no significant increase in mortality or 24‑hour intracerebral hemorrhage.
Read More
  • PASS: A Simplified Clinical Tool to Differentiate Acquired Aplastic Anemia from Inherited Bone Marrow Failure Syndromes in Adults
  • Harnessing Cardiac CT Radiomics of Epicardial Fat for Early Heart Failure Prediction
  • Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases
  • First Trimester Screening for Preterm Preeclampsia in the United Kingdom: Evaluating the Cost-Effectiveness of the FMF Strategy versus NICE Guidelines
  • Global Variations in Concurrent Hysterectomy During Risk-Reducing Surgery for BRCA1/2 Carriers: An Integrated Quantitative and Qualitative Analysis
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology health heart failure Hypertension immunotherapy inflammation MASLD mental health metformin Mortality myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prostate cancer public health quality of life randomized clinical trial randomized controlled trial randomized trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top
Sign in